Search Results - "Verdalles, U"

Refine Results
  1. 1
  2. 2

    Obesity related risk for chronic kidney disease progression and cardiovascular disease after propensity score matching by Barbieri, D., Goicoechea, M., García-Prieto, A., Delgado, A., Verde, E., Verdalles, U., Pérez de José, A., Carbayo, J., Muñoz de Morales, A., Luño, J.

    Published in Hipertension y riesgo vascular (01-04-2021)
    “…Obesity is a major health problem worldwide. It carries a markedly increased risk for multiple diseases such as type 2 diabetes mellitus, hypertension,…”
    Get full text
    Journal Article
  3. 3

    Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists by Verdalles, U., Goicoechea, M., García de Vinuesa, S., Torres, E., Hernández, A., Verde, E., Pérez de José, A., Luño, J.

    Published in Nefrología (01-01-2020)
    “…Actually, there are few data about glomerular filtration rate (eGFR) drop in patients with resistant hypertension and how different therapies can modify…”
    Get full text
    Journal Article
  4. 4

    The phase angle of the electrical impedance is a predictor of long-term survival in dialysis patients by Abad, S, Sotomayor, G, Vega, A, Pérez de José, A, Verdalles, U, Jofré, R, López-Gómez, J M

    “…Protein-energy malnutrition is a risk factor for mortality in dialysis patients; however, its clinical assessment has not been well defined. Electrical…”
    Get more information
    Journal Article
  5. 5

    Factors predicting mortality in elderly patients on dialysis by Verdalles, U, Abad, S, Aragoncillo, I, Villaverde, M, Jofre, R, Verde, E, Vega, A, López-Gómez, J M

    Published in Nephron. Clinical practice (01-01-2010)
    “…Elderly patients are increasingly enrolled in dialysis programs and present a series of special characteristics due to their high morbidity and mortality. To…”
    Get more information
    Journal Article
  6. 6

    Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease by Vega, A, Abad, S, Verdalles, U, Aragoncillo, I, Velazquez, K, Quiroga, B, Escudero, V, López-Gómez, J M

    Published in Hippokratia (01-01-2014)
    “…Anemia is a prevalent situation in patients with chronic kidney disease (CKD) and can be well managed with erythropoiesis-stimulating agents (ESAs). Continuous…”
    Get full text
    Journal Article
  7. 7

    Progresión de la enfermedad renal crónica en pacientes con hipertensión resistente sometidos a 2 estrategias terapéuticas: intensificación con diuréticos de asa vs. antagonistas de la aldosterona by Verdalles, U., Goicoechea, M., García de Vinuesa, S., Torres, E., Hernández, A., Verde, E., Pérez de José, A., Luño, J.

    Published in Nefrología (01-01-2020)
    “…En la actualidad, existen pocos datos sobre la evolución de la función renal en pacientes con hipertensión arterial (HTA) resistente y enfermedad renal crónica…”
    Get full text
    Journal Article
  8. 8

    Renin–angiotensin–aldosterone system blockers effect in chronic kidney disease progression in hypertensive elderly patients without proteinuria: PROERCAN trial by García-Prieto, A.M., Verdalles, Ú., de José, A.P., Arroyo, D., Aragoncillo, I., Barbieri, D., Camacho, R.E., Goicoechea, M.

    Published in Hipertension y riesgo vascular (01-04-2024)
    “…Evidence about nefroprotective effect with RAAS blockers in elderly patients with chronic kidney disease (CKD) without proteinuria is lacking. The primary…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Interarm systolic blood pressure as a predictor of cardiovascular events in patients with chronic kidney disease by Quiroga, Borja, Galán, Isabel, García de Vinuesa, Soledad, Goicoechea, Marian, Verdalles, Úrsula, Luño, José

    Published in Nephrology, dialysis, transplantation (01-05-2015)
    “…Increased interarm systolic blood pressure difference (IASBPD) is associated with mortality and cardiovascular (CV) events both in the general population and…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass by Galán, Isabel, Goicoechea, Marian, Quiroga, Borja, Macías, Nicolás, Santos, Alba, García de Vinuesa, Maria Soledad, Verdalles, Úrsula, Cedeño, Santiago, Verde, Eduardo, Pérez de José, Ana, García, Ana, Luño, José

    Published in Nefrología (01-01-2018)
    “…Hyperuricemia plays a major role in the development and progression of chronic kidney disease (CKD). Many large observational studies have indicated that…”
    Get full text
    Journal Article
  16. 16

    Utility of bioimpedance spectroscopy (BIS) in the management of refractory hypertension in patients with chronic kidney disease (CKD) by Verdalles, Ursula, de Vinuesa, Soledad García, Goicoechea, Marian, Quiroga, Borja, Reque, Javier, Panizo, Nayara, Arroyo, David, Luño, José

    Published in Nephrology, dialysis, transplantation (01-12-2012)
    “…Expansion of extracellular volume (ECV) is a frequent cause of resistant hypertension (RHT) in patients with chronic kidney disease (CKD). The aim of this…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Calciphylaxis: fatal complication of cardiometabolic syndrome in patients with end stage kidney disease by Verdalles Guzmán, U, de la Cueva, P, Verde, E, García de Vinuesa, S, Goicoechea, M, Mosse, A, López Gómez, J M, Luño, J

    Published in Nefrología (2008)
    “…Calciphylaxis characterized by schemic skin ulceration due to subcutaneous small arterioles calcification, is a rare disease but usually fatal. Disorders of…”
    Get full text
    Journal Article
  19. 19
  20. 20